MCM
BIIB icon

McKinley Capital Management’s Biogen BIIB Stock Holding History

McKinley Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,220
Closed -$2.89M – 177
2021
Q3 		$2.89M Hold
10,220
– – 0.27% 108
2021
Q2 		$3.54M Hold
10,220
– – 0.25% 100
2021
Q1 		$2.86M Hold
10,220
– – 0.22% 110
2020
Q4 		$2.5M Buy
+10,220
New +$2.64M 0.18% 114
2019
Q2 		– Sell
-239
Closed -$56K – 218
2019
Q1 		$56K Sell
239
-823
-77% -$259K ﹤0.01% 219
2018
Q4 		$320K Buy
1,062
+336
+46% +$107K 0.03% 173
2018
Q3 		$257K Buy
+726
New +$250K 0.02% 185
2018
Q2 		– Sell
-673
Closed -$185K – 306
2018
Q1 		$185K Buy
+673
New +$209K 0.01% 219
2017
Q2 		– Sell
-9,185
Closed -$2.51M – 469
2017
Q1 		$2.51M Sell
9,185
-99,374
-92% -$28.1M 0.09% 150
2016
Q4 		$30.8M Buy
108,559
+7,296
+7% +$2.16M 1.21% 25
2016
Q3 		$31.7M Buy
101,263
+25,731
+34% +$7.62M 1.14% 26
2016
Q2 		$18.3M Sell
75,532
-9,939
-12% -$2.62M 0.88% 33
2016
Q1 		$22.3M Sell
85,471
-36,327
-30% -$9.6M 1.07% 24
2015
Q4 		$37.3M Buy
121,798
+53,787
+79% +$15.5M 1.73% 9
2015
Q3 		$19.8M Sell
68,011
-200
-0.3% -$66K 0.97% 28
2015
Q2 		$27.6M Sell
68,211
-23,562
-26% -$9.46M 1.18% 25
2015
Q1 		$38.8M Sell
91,773
-23,998
-21% -$9.46M 1.55% 11
2014
Q4 		$39.3M Sell
115,771
-6,853
-6% -$2.22M 1.58% 12
2014
Q3 		$40.6M Sell
122,624
-5,416
-4% -$1.79M 1.79% 8
2014
Q2 		$40.4M Sell
128,040
-26,835
-17% -$8.08M 1.66% 9
2014
Q1 		$47.4M Sell
154,875
-25,853
-14% -$8.21M 1.99% 8
2013
Q4 		$50.5M Sell
180,728
-82
-0% -$21.2K 1.98% 7
2013
Q3 		$43.5M Sell
180,810
-31,320
-15% -$7.01M 1.9% 4
2013
Q2 		$45.6M Buy
+212,130
New +$45.3M 2.29% 3

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

McKinley Capital Management's BIIB Position: Q4 2021 in Review

McKinley Capital Management sold out of Biogen (BIIB) in Q4 2021, closing a stake of 10,220 shares — an estimated $2.89M sold.

McKinley Capital Management first reported a position in BIIB in Q2 2013 and held it in 24 quarters. The position peaked at $50.5M in Q4 2013. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • McKinley Capital Management reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • McKinley Capital Management sold 10,220 Biogen shares in Q4 2021, an estimated $2.89M.
  • McKinley Capital Management first reported a position in Biogen in Q2 2013 and held it in 24 quarters.
  • McKinley Capital Management's Biogen position peaked at $50.5M in Q4 2013.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on McKinley Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.